b872f2e4f9157338bbe3c3167acd60c6 *DESCRIPTION
6e45604d2c5e85d4d2e080bcf445c0a4 *NAMESPACE
6f86d2141731b2384afccad574107149 *NEWS
d653aa2bf08c95abc1539ca2fb2cb078 *R/interim.r
d4d017aaa72e40d318de4fbf3ea4d4ff *man/capacity.Rd
a7186e0cf7f1aa387626e951853a2d83 *man/convertedRate.Rd
41c11418cb4ed0dabf4a0b5439e83257 *man/cross.Rd
50ffc318fa04bb048198f18875b28b7e *man/event.Rd
f210f90f67c2700063cc024621d57bff *man/eventCourse.Rd
e8849c7be5c6a3c172126f776aa1e1d8 *man/eventWeek.Rd
e3ce2628bbebb26a98a30809e18daab9 *man/interim-package.Rd
1a468db0819adbccd7a00ec9878ea475 *man/recruitment.Rd
2e26eb08acc2d03db63d9d659f90ac3c *man/treatment.Rd
e54715535edc993313c1121d713058e3 *man/trialCourse.Rd
ac9237bd72fe821655b62912a630962f *man/trialWeek.Rd
